Sanofi India Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Key Metrics
PE ratio
26.69
PB ratio
11.14
Dividend yield
5.04%
Beta
0.01
Market cap
₹87.24B
Enterprise value
₹84.60B
Company profile
| Industry / Sector | Drug Manufacturers - General / Healthcare |
|---|---|
| Full time employees | 1225 |
| Website | https://www.sanofi.com/en/india/investors |
| Mailing address | Sanofi House CTS No. 117-B, L&T Business Park Saki Vihar Road Powai Mumbai 400072 India |
| Phone / Fax | 91 22 2803 2000 / 91 22 2803 2939 |
Dividends
Dividend yield
5.04%
Dividend amount
₹192.00
Payout ratio
135.35%
5Y Avg. yield
-%
Sanofi India Limited paid ₹192.00 dividend and the ex-dividend date was 07 Nov 2025.The dividend payout ratio is 135.35%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SANOFI dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Sanofi India Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Rachid Ayari | CFO & Whole Time Director | 50 | |
| Mr. Deepak Arora | Country Lead, Managing Director & General Manager of Pharma | ||
| Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. | Senior Director of Accounting & Taxation | 70 | |
| Ms. Sudipta Chakraborty | Head of Legal | ||
| Mr. Haresh Bachubhai Vala | Company Secretary & Compliance Officer | ||
| Ms. Richa Bakshi | Head of People Excellence | ||
| Mr. Sanjay V. Chavan | Head of Country Procurement - India | 63 | |
| Mr. Nakul Verma | Senior Director of Public Affairs and Head of Public Affairs & Market Access | ||
| Mr. Bratin Bag | Senior Director of Ethics & Business Integrity, South Asia | ||
| Mr. Mahadev Gawade | Additional Whole-time Director & Site Director - Goa |
Profitability and management effectiveness
Profit margin
18.43%
Operating margin
19.25%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Sanofi India Limited is 87.24B and its enterprise value is 84.60B. The enterprise value to revenue ratio of SANOFI is 4.38. The enterprise value to EBITDA ratio of SANOFI is 16.34.
The SANOFI's stocks Beta value is 0.01 making it 99% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Sanofi India Limited (NSE:SANOFI) Frequently Asked Questions
1. What is Sanofi India Limited's Stock Symbol?
Sanofi India Limited trades on NSE under the ticker symbol "SANOFI".
2. What is Sanofi India Limited's stock price today?
One share of SANOFI stock can currently be purchased for approximately ₹3783.8.
3. How can I contact Sanofi India Limited?
Sanofi India Limited's mailing address is Sanofi House CTS No. 117-B, L&T Business Park Saki Vihar Road Powai Mumbai 400072 India. The company can be reached via phone at 91 22 2803 2000.
4. What is Sanofi India Limited's official website?
The official website of Sanofi India Limited is https://www.sanofi.com/en/india/investors.